nodes	percent_of_prediction	percent_of_DWPC	metapath
Methocarbamol—Nasal congestion—Tretinoin—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Methocarbamol—Nasal congestion—Isotretinoin—peripheral nervous system neoplasm	0.0127	0.0127	CcSEcCtD
Methocarbamol—Lightheadedness—Alitretinoin—peripheral nervous system neoplasm	0.0108	0.0108	CcSEcCtD
Methocarbamol—Nasal congestion—Alitretinoin—peripheral nervous system neoplasm	0.00961	0.00961	CcSEcCtD
Methocarbamol—Drowsiness—Tretinoin—peripheral nervous system neoplasm	0.0089	0.0089	CcSEcCtD
Methocarbamol—Drowsiness—Isotretinoin—peripheral nervous system neoplasm	0.0089	0.0089	CcSEcCtD
Methocarbamol—Conjunctivitis—Tretinoin—peripheral nervous system neoplasm	0.00865	0.00865	CcSEcCtD
Methocarbamol—Conjunctivitis—Isotretinoin—peripheral nervous system neoplasm	0.00865	0.00865	CcSEcCtD
Methocarbamol—Jaundice—Melphalan—peripheral nervous system neoplasm	0.00857	0.00857	CcSEcCtD
Methocarbamol—Nasal congestion—Cisplatin—peripheral nervous system neoplasm	0.00819	0.00819	CcSEcCtD
Methocarbamol—Amnesia—Cisplatin—peripheral nervous system neoplasm	0.00794	0.00794	CcSEcCtD
Methocarbamol—Flushing—Tretinoin—peripheral nervous system neoplasm	0.00742	0.00742	CcSEcCtD
Methocarbamol—Flushing—Isotretinoin—peripheral nervous system neoplasm	0.00742	0.00742	CcSEcCtD
Methocarbamol—Nystagmus—Epirubicin—peripheral nervous system neoplasm	0.00739	0.00739	CcSEcCtD
Methocarbamol—Flushing—Melphalan—peripheral nervous system neoplasm	0.00732	0.00732	CcSEcCtD
Methocarbamol—Nystagmus—Doxorubicin—peripheral nervous system neoplasm	0.00684	0.00684	CcSEcCtD
Methocarbamol—Drowsiness—Alitretinoin—peripheral nervous system neoplasm	0.00675	0.00675	CcSEcCtD
Methocarbamol—Conjunctivitis—Alitretinoin—peripheral nervous system neoplasm	0.00656	0.00656	CcSEcCtD
Methocarbamol—Vision blurred—Tretinoin—peripheral nervous system neoplasm	0.00656	0.00656	CcSEcCtD
Methocarbamol—Vision blurred—Isotretinoin—peripheral nervous system neoplasm	0.00656	0.00656	CcSEcCtD
Methocarbamol—Angioedema—Topotecan—peripheral nervous system neoplasm	0.00641	0.00641	CcSEcCtD
Methocarbamol—Leukopenia—Topotecan—peripheral nervous system neoplasm	0.00628	0.00628	CcSEcCtD
Methocarbamol—Syncope—Tretinoin—peripheral nervous system neoplasm	0.00624	0.00624	CcSEcCtD
Methocarbamol—Syncope—Isotretinoin—peripheral nervous system neoplasm	0.00624	0.00624	CcSEcCtD
Methocarbamol—Leukopenia—Melphalan—peripheral nervous system neoplasm	0.00615	0.00615	CcSEcCtD
Methocarbamol—Loss of consciousness—Isotretinoin—peripheral nervous system neoplasm	0.00611	0.00611	CcSEcCtD
Methocarbamol—Loss of consciousness—Tretinoin—peripheral nervous system neoplasm	0.00611	0.00611	CcSEcCtD
Methocarbamol—Flushing—Dactinomycin—peripheral nervous system neoplasm	0.00606	0.00606	CcSEcCtD
Methocarbamol—Convulsion—Isotretinoin—peripheral nervous system neoplasm	0.00603	0.00603	CcSEcCtD
Methocarbamol—Convulsion—Tretinoin—peripheral nervous system neoplasm	0.00603	0.00603	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Epirubicin—peripheral nervous system neoplasm	0.00601	0.00601	CcSEcCtD
Methocarbamol—Convulsion—Melphalan—peripheral nervous system neoplasm	0.00595	0.00595	CcSEcCtD
Methocarbamol—Confusional state—Tretinoin—peripheral nervous system neoplasm	0.00572	0.00572	CcSEcCtD
Methocarbamol—Confusional state—Isotretinoin—peripheral nervous system neoplasm	0.00572	0.00572	CcSEcCtD
Methocarbamol—Anaphylactic shock—Topotecan—peripheral nervous system neoplasm	0.00572	0.00572	CcSEcCtD
Methocarbamol—Anaphylactic shock—Isotretinoin—peripheral nervous system neoplasm	0.00568	0.00568	CcSEcCtD
Methocarbamol—Anaphylactic shock—Tretinoin—peripheral nervous system neoplasm	0.00568	0.00568	CcSEcCtD
Methocarbamol—Flushing—Alitretinoin—peripheral nervous system neoplasm	0.00562	0.00562	CcSEcCtD
Methocarbamol—Anaphylactic shock—Melphalan—peripheral nervous system neoplasm	0.0056	0.0056	CcSEcCtD
Methocarbamol—Conjunctivitis—Cisplatin—peripheral nervous system neoplasm	0.00559	0.00559	CcSEcCtD
Methocarbamol—Shock—Tretinoin—peripheral nervous system neoplasm	0.00559	0.00559	CcSEcCtD
Methocarbamol—Shock—Isotretinoin—peripheral nervous system neoplasm	0.00559	0.00559	CcSEcCtD
Methocarbamol—Jaundice cholestatic—Doxorubicin—peripheral nervous system neoplasm	0.00556	0.00556	CcSEcCtD
Methocarbamol—Coordination abnormal—Epirubicin—peripheral nervous system neoplasm	0.00537	0.00537	CcSEcCtD
Methocarbamol—Hypotension—Isotretinoin—peripheral nervous system neoplasm	0.00531	0.00531	CcSEcCtD
Methocarbamol—Hypotension—Tretinoin—peripheral nervous system neoplasm	0.00531	0.00531	CcSEcCtD
Methocarbamol—Bradycardia—Cisplatin—peripheral nervous system neoplasm	0.00525	0.00525	CcSEcCtD
Methocarbamol—Hypotension—Melphalan—peripheral nervous system neoplasm	0.00524	0.00524	CcSEcCtD
Methocarbamol—Insomnia—Tretinoin—peripheral nervous system neoplasm	0.00514	0.00514	CcSEcCtD
Methocarbamol—Insomnia—Isotretinoin—peripheral nervous system neoplasm	0.00514	0.00514	CcSEcCtD
Methocarbamol—Jaundice—Etoposide—peripheral nervous system neoplasm	0.00513	0.00513	CcSEcCtD
Methocarbamol—Leukopenia—Dactinomycin—peripheral nervous system neoplasm	0.00509	0.00509	CcSEcCtD
Methocarbamol—Somnolence—Tretinoin—peripheral nervous system neoplasm	0.00505	0.00505	CcSEcCtD
Methocarbamol—Somnolence—Isotretinoin—peripheral nervous system neoplasm	0.00505	0.00505	CcSEcCtD
Methocarbamol—Dyspepsia—Topotecan—peripheral nervous system neoplasm	0.00504	0.00504	CcSEcCtD
Methocarbamol—Dyspepsia—Tretinoin—peripheral nervous system neoplasm	0.005	0.005	CcSEcCtD
Methocarbamol—Dyspepsia—Isotretinoin—peripheral nervous system neoplasm	0.005	0.005	CcSEcCtD
Methocarbamol—Coordination abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00497	0.00497	CcSEcCtD
Methocarbamol—Vision blurred—Alitretinoin—peripheral nervous system neoplasm	0.00497	0.00497	CcSEcCtD
Methocarbamol—Dyspepsia—Melphalan—peripheral nervous system neoplasm	0.00493	0.00493	CcSEcCtD
Methocarbamol—Pain—Topotecan—peripheral nervous system neoplasm	0.00489	0.00489	CcSEcCtD
Methocarbamol—Pain—Isotretinoin—peripheral nervous system neoplasm	0.00486	0.00486	CcSEcCtD
Methocarbamol—Pain—Tretinoin—peripheral nervous system neoplasm	0.00486	0.00486	CcSEcCtD
Methocarbamol—Pain—Melphalan—peripheral nervous system neoplasm	0.00479	0.00479	CcSEcCtD
Methocarbamol—Flushing—Cisplatin—peripheral nervous system neoplasm	0.00479	0.00479	CcSEcCtD
Methocarbamol—Syncope—Alitretinoin—peripheral nervous system neoplasm	0.00473	0.00473	CcSEcCtD
Methocarbamol—Feeling abnormal—Topotecan—peripheral nervous system neoplasm	0.00472	0.00472	CcSEcCtD
Methocarbamol—Feeling abnormal—Tretinoin—peripheral nervous system neoplasm	0.00468	0.00468	CcSEcCtD
Methocarbamol—Feeling abnormal—Isotretinoin—peripheral nervous system neoplasm	0.00468	0.00468	CcSEcCtD
Methocarbamol—Loss of consciousness—Alitretinoin—peripheral nervous system neoplasm	0.00463	0.00463	CcSEcCtD
Methocarbamol—Convulsion—Alitretinoin—peripheral nervous system neoplasm	0.00457	0.00457	CcSEcCtD
Methocarbamol—Vertigo—Vincristine—peripheral nervous system neoplasm	0.00456	0.00456	CcSEcCtD
Methocarbamol—Leukopenia—Vincristine—peripheral nervous system neoplasm	0.00455	0.00455	CcSEcCtD
Methocarbamol—Urticaria—Topotecan—peripheral nervous system neoplasm	0.00455	0.00455	CcSEcCtD
Methocarbamol—Body temperature increased—Topotecan—peripheral nervous system neoplasm	0.00452	0.00452	CcSEcCtD
Methocarbamol—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.00451	0.00451	CcSEcCtD
Methocarbamol—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.00451	0.00451	CcSEcCtD
Methocarbamol—Body temperature increased—Tretinoin—peripheral nervous system neoplasm	0.00449	0.00449	CcSEcCtD
Methocarbamol—Body temperature increased—Isotretinoin—peripheral nervous system neoplasm	0.00449	0.00449	CcSEcCtD
Methocarbamol—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00445	0.00445	CcSEcCtD
Methocarbamol—Thrombophlebitis—Epirubicin—peripheral nervous system neoplasm	0.00443	0.00443	CcSEcCtD
Methocarbamol—Convulsion—Vincristine—peripheral nervous system neoplasm	0.0044	0.0044	CcSEcCtD
Methocarbamol—Flushing—Etoposide—peripheral nervous system neoplasm	0.00439	0.00439	CcSEcCtD
Methocarbamol—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.00434	0.00434	CcSEcCtD
Methocarbamol—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.0043	0.0043	CcSEcCtD
Methocarbamol—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.00423	0.00423	CcSEcCtD
Methocarbamol—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00423	0.00423	CcSEcCtD
Methocarbamol—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.00422	0.00422	CcSEcCtD
Methocarbamol—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.00418	0.00418	CcSEcCtD
Methocarbamol—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.00418	0.00418	CcSEcCtD
Methocarbamol—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00415	0.00415	CcSEcCtD
Methocarbamol—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.00413	0.00413	CcSEcCtD
Methocarbamol—Thrombophlebitis—Doxorubicin—peripheral nervous system neoplasm	0.00409	0.00409	CcSEcCtD
Methocarbamol—Pruritus—Topotecan—peripheral nervous system neoplasm	0.00405	0.00405	CcSEcCtD
Methocarbamol—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.00403	0.00403	CcSEcCtD
Methocarbamol—Leukopenia—Cisplatin—peripheral nervous system neoplasm	0.00402	0.00402	CcSEcCtD
Methocarbamol—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.00402	0.00402	CcSEcCtD
Methocarbamol—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.00402	0.00402	CcSEcCtD
Methocarbamol—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.00402	0.00402	CcSEcCtD
Methocarbamol—Pain—Dactinomycin—peripheral nervous system neoplasm	0.00397	0.00397	CcSEcCtD
Methocarbamol—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00397	0.00397	CcSEcCtD
Methocarbamol—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.00389	0.00389	CcSEcCtD
Methocarbamol—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.00389	0.00389	CcSEcCtD
Methocarbamol—Hypotension—Vincristine—peripheral nervous system neoplasm	0.00387	0.00387	CcSEcCtD
Methocarbamol—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.00383	0.00383	CcSEcCtD
Methocarbamol—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.00383	0.00383	CcSEcCtD
Methocarbamol—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.00382	0.00382	CcSEcCtD
Methocarbamol—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.00379	0.00379	CcSEcCtD
Methocarbamol—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00378	0.00378	CcSEcCtD
Methocarbamol—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.00375	0.00375	CcSEcCtD
Methocarbamol—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.00375	0.00375	CcSEcCtD
Methocarbamol—Insomnia—Vincristine—peripheral nervous system neoplasm	0.00375	0.00375	CcSEcCtD
Methocarbamol—Vertigo—Etoposide—peripheral nervous system neoplasm	0.0037	0.0037	CcSEcCtD
Methocarbamol—Leukopenia—Etoposide—peripheral nervous system neoplasm	0.00368	0.00368	CcSEcCtD
Methocarbamol—Pain—Alitretinoin—peripheral nervous system neoplasm	0.00368	0.00368	CcSEcCtD
Methocarbamol—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.00367	0.00367	CcSEcCtD
Methocarbamol—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.00367	0.00367	CcSEcCtD
Methocarbamol—Vomiting—Topotecan—peripheral nervous system neoplasm	0.00364	0.00364	CcSEcCtD
Methocarbamol—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.00362	0.00362	CcSEcCtD
Methocarbamol—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.00361	0.00361	CcSEcCtD
Methocarbamol—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.00361	0.00361	CcSEcCtD
Methocarbamol—Rash—Topotecan—peripheral nervous system neoplasm	0.00361	0.00361	CcSEcCtD
Methocarbamol—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.00361	0.00361	CcSEcCtD
Methocarbamol—Headache—Topotecan—peripheral nervous system neoplasm	0.00359	0.00359	CcSEcCtD
Methocarbamol—Rash—Tretinoin—peripheral nervous system neoplasm	0.00358	0.00358	CcSEcCtD
Methocarbamol—Rash—Isotretinoin—peripheral nervous system neoplasm	0.00358	0.00358	CcSEcCtD
Methocarbamol—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.00358	0.00358	CcSEcCtD
Methocarbamol—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.00358	0.00358	CcSEcCtD
Methocarbamol—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00357	0.00357	CcSEcCtD
Methocarbamol—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00356	0.00356	CcSEcCtD
Methocarbamol—Headache—Tretinoin—peripheral nervous system neoplasm	0.00356	0.00356	CcSEcCtD
Methocarbamol—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00356	0.00356	CcSEcCtD
Methocarbamol—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00355	0.00355	CcSEcCtD
Methocarbamol—Pain—Vincristine—peripheral nervous system neoplasm	0.00355	0.00355	CcSEcCtD
Methocarbamol—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.00354	0.00354	CcSEcCtD
Methocarbamol—Rash—Melphalan—peripheral nervous system neoplasm	0.00353	0.00353	CcSEcCtD
Methocarbamol—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.00353	0.00353	CcSEcCtD
Methocarbamol—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.00343	0.00343	CcSEcCtD
Methocarbamol—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.00342	0.00342	CcSEcCtD
Methocarbamol—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.00342	0.00342	CcSEcCtD
Methocarbamol—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.0034	0.0034	CcSEcCtD
Methocarbamol—Nausea—Topotecan—peripheral nervous system neoplasm	0.0034	0.0034	CcSEcCtD
Methocarbamol—Confusional state—Etoposide—peripheral nervous system neoplasm	0.00339	0.00339	CcSEcCtD
Methocarbamol—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00337	0.00337	CcSEcCtD
Methocarbamol—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00337	0.00337	CcSEcCtD
Methocarbamol—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.00336	0.00336	CcSEcCtD
Methocarbamol—Nausea—Melphalan—peripheral nervous system neoplasm	0.00333	0.00333	CcSEcCtD
Methocarbamol—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.00328	0.00328	CcSEcCtD
Methocarbamol—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.00317	0.00317	CcSEcCtD
Methocarbamol—Hypotension—Etoposide—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Methocarbamol—Pain—Cisplatin—peripheral nervous system neoplasm	0.00314	0.00314	CcSEcCtD
Methocarbamol—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.00305	0.00305	CcSEcCtD
Methocarbamol—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.00304	0.00304	CcSEcCtD
Methocarbamol—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00302	0.00302	CcSEcCtD
Methocarbamol—Somnolence—Etoposide—peripheral nervous system neoplasm	0.00299	0.00299	CcSEcCtD
Methocarbamol—Drowsiness—Epirubicin—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Methocarbamol—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.00295	0.00295	CcSEcCtD
Methocarbamol—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00293	0.00293	CcSEcCtD
Methocarbamol—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.0029	0.0029	CcSEcCtD
Methocarbamol—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.00288	0.00288	CcSEcCtD
Methocarbamol—Pain—Etoposide—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Methocarbamol—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.00287	0.00287	CcSEcCtD
Methocarbamol—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00285	0.00285	CcSEcCtD
Methocarbamol—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00277	0.00277	CcSEcCtD
Methocarbamol—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00276	0.00276	CcSEcCtD
Methocarbamol—Dizziness—Vincristine—peripheral nervous system neoplasm	0.00274	0.00274	CcSEcCtD
Methocarbamol—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.00274	0.00274	CcSEcCtD
Methocarbamol—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	0.00273	0.00273	CcSEcCtD
Methocarbamol—Rash—Alitretinoin—peripheral nervous system neoplasm	0.00271	0.00271	CcSEcCtD
Methocarbamol—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.00271	0.00271	CcSEcCtD
Methocarbamol—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.0027	0.0027	CcSEcCtD
Methocarbamol—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.0027	0.0027	CcSEcCtD
Methocarbamol—Headache—Alitretinoin—peripheral nervous system neoplasm	0.0027	0.0027	CcSEcCtD
Methocarbamol—Urticaria—Etoposide—peripheral nervous system neoplasm	0.00267	0.00267	CcSEcCtD
Methocarbamol—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.00266	0.00266	CcSEcCtD
Methocarbamol—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00266	0.00266	CcSEcCtD
Methocarbamol—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.00266	0.00266	CcSEcCtD
Methocarbamol—Vomiting—Vincristine—peripheral nervous system neoplasm	0.00264	0.00264	CcSEcCtD
Methocarbamol—Rash—Vincristine—peripheral nervous system neoplasm	0.00261	0.00261	CcSEcCtD
Methocarbamol—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00261	0.00261	CcSEcCtD
Methocarbamol—Headache—Vincristine—peripheral nervous system neoplasm	0.0026	0.0026	CcSEcCtD
Methocarbamol—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.00256	0.00256	CcSEcCtD
Methocarbamol—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.0025	0.0025	CcSEcCtD
Methocarbamol—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00247	0.00247	CcSEcCtD
Methocarbamol—Nausea—Vincristine—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Methocarbamol—Flushing—Epirubicin—peripheral nervous system neoplasm	0.00246	0.00246	CcSEcCtD
Methocarbamol—Pruritus—Etoposide—peripheral nervous system neoplasm	0.00238	0.00238	CcSEcCtD
Methocarbamol—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00233	0.00233	CcSEcCtD
Methocarbamol—Rash—Cisplatin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Methocarbamol—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00231	0.00231	CcSEcCtD
Methocarbamol—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.00228	0.00228	CcSEcCtD
Methocarbamol—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	0.00226	0.00226	CcSEcCtD
Methocarbamol—Dizziness—Etoposide—peripheral nervous system neoplasm	0.00222	0.00222	CcSEcCtD
Methocarbamol—Nausea—Cisplatin—peripheral nervous system neoplasm	0.00218	0.00218	CcSEcCtD
Methocarbamol—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00217	0.00217	CcSEcCtD
Methocarbamol—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00214	0.00214	CcSEcCtD
Methocarbamol—Rash—Etoposide—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Methocarbamol—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00212	0.00212	CcSEcCtD
Methocarbamol—Headache—Etoposide—peripheral nervous system neoplasm	0.0021	0.0021	CcSEcCtD
Methocarbamol—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	0.00209	0.00209	CcSEcCtD
Methocarbamol—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Methocarbamol—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00207	0.00207	CcSEcCtD
Methocarbamol—Leukopenia—Epirubicin—peripheral nervous system neoplasm	0.00206	0.00206	CcSEcCtD
Methocarbamol—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.00203	0.00203	CcSEcCtD
Methocarbamol—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.00201	0.00201	CcSEcCtD
Methocarbamol—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Methocarbamol—Nausea—Etoposide—peripheral nervous system neoplasm	0.002	0.002	CcSEcCtD
Methocarbamol—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.00192	0.00192	CcSEcCtD
Methocarbamol—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Methocarbamol—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	0.00191	0.00191	CcSEcCtD
Methocarbamol—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.0019	0.0019	CcSEcCtD
Methocarbamol—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Methocarbamol—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.00188	0.00188	CcSEcCtD
Methocarbamol—Shock—Epirubicin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Methocarbamol—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.00185	0.00185	CcSEcCtD
Methocarbamol—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Methocarbamol—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00176	0.00176	CcSEcCtD
Methocarbamol—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	0.00174	0.00174	CcSEcCtD
Methocarbamol—Shock—Doxorubicin—peripheral nervous system neoplasm	0.00171	0.00171	CcSEcCtD
Methocarbamol—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.0017	0.0017	CcSEcCtD
Methocarbamol—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.00167	0.00167	CcSEcCtD
Methocarbamol—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.00166	0.00166	CcSEcCtD
Methocarbamol—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00163	0.00163	CcSEcCtD
Methocarbamol—Pain—Epirubicin—peripheral nervous system neoplasm	0.00161	0.00161	CcSEcCtD
Methocarbamol—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00158	0.00158	CcSEcCtD
Methocarbamol—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Methocarbamol—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.00155	0.00155	CcSEcCtD
Methocarbamol—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00153	0.00153	CcSEcCtD
Methocarbamol—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.0015	0.0015	CcSEcCtD
Methocarbamol—Pain—Doxorubicin—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Methocarbamol—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	0.00149	0.00149	CcSEcCtD
Methocarbamol—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.00144	0.00144	CcSEcCtD
Methocarbamol—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.00139	0.00139	CcSEcCtD
Methocarbamol—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Methocarbamol—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	0.00138	0.00138	CcSEcCtD
Methocarbamol—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.00133	0.00133	CcSEcCtD
Methocarbamol—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.00128	0.00128	CcSEcCtD
Methocarbamol—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.00125	0.00125	CcSEcCtD
Methocarbamol—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.00123	0.00123	CcSEcCtD
Methocarbamol—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.0012	0.0012	CcSEcCtD
Methocarbamol—Rash—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Methocarbamol—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.00119	0.00119	CcSEcCtD
Methocarbamol—Headache—Epirubicin—peripheral nervous system neoplasm	0.00118	0.00118	CcSEcCtD
Methocarbamol—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.00115	0.00115	CcSEcCtD
Methocarbamol—Nausea—Epirubicin—peripheral nervous system neoplasm	0.00112	0.00112	CcSEcCtD
Methocarbamol—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.00111	0.00111	CcSEcCtD
Methocarbamol—Rash—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Methocarbamol—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.0011	0.0011	CcSEcCtD
Methocarbamol—Headache—Doxorubicin—peripheral nervous system neoplasm	0.00109	0.00109	CcSEcCtD
Methocarbamol—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00103	0.00103	CcSEcCtD
